Videos de Experimentos Relacionados
Prescripción adecuada en personas mayores: ¿qué tan bien se puede medir y optimizar?
Anne Spinewine1, Kenneth E Schmader2, Nick Barber3
1Center for Clinical Pharmacy, School of Pharmacy, Université catholique de Louvain, Brussels, Belgium.
Lancet (London, England)
|July 17, 2007
Resumen
La optimización de la medicación para los adultos mayores es crucial. Esta revisión define la prescripción adecuada, evalúa las herramientas de medición y evalúa las intervenciones para mejorar el uso de drogas en los ancianos.
Área de la Ciencia:
- Medicina Geriátrica La medicina geriátrica es una especialidad de la medicina geriátrica.
- La farmacoterapia es la farmacoterapia.
- Salud Pública La salud pública.
Sus antecedentes:
- La prescripción de medicamentos es vital para el cuidado de las personas mayores.
- El envejecimiento y la medicina geriátrica presentan desafíos únicos en la farmacoterapia.
- La optimización de la prescripción de medicamentos para los ancianos es una prioridad mundial de salud pública.
Objetivo del estudio:
- Definir y categorizar la prescripción apropiada en personas mayores.
- Revise críticamente los instrumentos para medir la adecuación de la prescripción y su validez.
- Evaluar los estudios de intervención sobre la prescripción de estrategias de optimización en los ancianos.
Principales métodos:
- Revisión de la literatura de instrumentos y estudios de intervención.
- Evaluación crítica de la validez predictiva de las herramientas de medición.
- Análisis de ensayos controlados aleatorios sobre la optimización de la prescripción.
Principales resultados:
- El estudio define la prescripción adecuada para los adultos mayores.
- Revisa y evalúa las herramientas para medir la adecuación de la prescripción.
- Examina críticamente los estudios de intervención sobre la optimización de la medicación en los ancianos.
Conclusiones:
- La prescripción adecuada en los ancianos requiere una cuidadosa consideración de los factores de envejecimiento.
- Los instrumentos validados son esenciales para medir la calidad de la prescripción.
- Se necesitan más investigaciones y prácticas para optimizar la farmacoterapia para las poblaciones mayores.
Videos de Conceptos Relacionados
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...